Particle.news
Patient Outcomes Drug Development AI in Medicine Male Contraceptive Trials Contraceptive Trials Antidepressants Gene Therapy Trials Weight Loss Drugs Drug Safety Trials Approval Process Pre-Clinical Trials Drug Development Stages Neurological Diseases Mental Health Cardiovascular Diseases Addiction Self-Testing Trials Animal Studies Pharmaceuticals Screening Methods Transplant Research Research Tools Mitochondrial Disease Research Endoscopic Procedures Hormonal Therapies Primate Research CAR T-cell Therapy Alzheimer's Disease Stem Cell Therapy Mitochondrial Donation Cell Therapy Psychedelic Therapy Brain Cancer Clinical Trials Placebo Effect ADPKD Clinical Trials Effectiveness of Weight Loss Medications Drug Trials Phase II Trials Treatment Innovations Psychiatric Disorders HIV Aural Toileting Fertility Research Pregnancy Loss Treatments Preventive Medicine Alzheimer's Disease Research Surgical Interventions Antihypertensive Drugs mRNA Technology Therapies Cystic Fibrosis Randomized Controlled Trials Funding Challenges Immune System Disorders Experimental Treatments DFMO Treatment Phase 1/2 Studies Preclinical Studies Patient Studies Innovative Treatments Biomarkers Gene Therapy Type 2 Diabetes Phase 2 Trials Cancer Treatment Cancer Research Vaccine Trials
Researchers say extended follow-up reveals delayed gains for patients labeled drug-resistant.
